Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current research centers on addressing the underlying pathophysiology of MSA. One avenue under investigation involves pharmacological interventions to regulate the acti